Onset and Disease Course of Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitor Therapy at a Single Institution

被引：0
|
作者：
Boutsicaris, Christina [1 ]
Ciliberti, Angelo [2 ]
Lockerman, Elizabeth [1 ]
Siddique, Faizah [3 ]
Ostrowski, Rochella [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Loyola Univ Med Ctr, Oak Pk, IL USA
[3] Loyola Univ Med Ctr, Lombard, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1566
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
    Chen, Hsing-Wu
    Kuo, Yao-Wen
    Chen, Chung-Yu
    Chang, Chin-Hao
    Wang, Su-Mei
    Chien, Ying-Chun
    Lu, Wei-Chen
    Chen, Jo-Pai
    Chang, Cheng-Yu
    Wei, Yu-Feng
    Chang, Shih-Chieh
    Shu, Chin-Chung
    Wang, Jann-Yuan
    Liao, Wei-Yu
    Wang, Hao-Chien
    Yu, Chong-Jen
    ONCOLOGIST, 2024, 29 (04): : e498 - e506
  • [42] Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
    Ardeshir-Larijani, Fatemeh
    Nelson, Ariel Ann
    Martin, Petra
    Mendiratta, Prateek
    Sloan, Andrew E.
    Choi, Serah
    Mansur, David B.
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Clinical and Histopathologic Features of Adverse Pulmonary Reactions in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Larsen, Brandon
    Chae, June
    Dixit, Anuj
    Hartman, Thomas
    Peikert, Tobias
    Roden, Anja
    LABORATORY INVESTIGATION, 2019, 99
  • [44] Emerging concern of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kanai, Osamu
    Kim, Young Hak
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kim, Young Hak
    Kanai, Osamu
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    RESPIRATORY MEDICINE, 2019, 146 : 66 - 70
  • [46] Clinical and Histopathologic Features of Adverse Pulmonary Reactions in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Larsen, Brandon
    Chae, June
    Dixit, Anuj
    Hartman, Thomas
    Peikert, Tobias
    Roden, Anja
    MODERN PATHOLOGY, 2019, 32
  • [47] CHARACTERISTICS AND TREATMENT OF NEW ONSET ARTHRITIS AFTER CHECKPOINT INHIBITOR THERAPY
    Christ, L. A.
    Moench, S.
    Hasmann, S.
    Goldscheider, I.
    Heppt, M.
    Berking, C.
    Berger, F.
    Dechant, C.
    Skapenko, A.
    Schulze-Koops, H.
    Leipe, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 718 - 718
  • [48] Clinical features of immune checkpoint inhibitor-induced inflammatory arthritis differ in those treated with combination versus single agent therapy
    Cappelli, Laura
    Bingham, Clifton
    Brahmer, Julie
    Forde, Patrick
    Le, Dung
    Lipson, Evan
    Naidoo, Jarushka
    Zhang, Lei
    Shah, Ami
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [49] Hyperprogressive disease in patients receiving immune checkpoint inhibitors
    Zhang, Haochen
    Fang, Xuefeng
    Li, Dan
    Yang, Mengyuan
    Yu, Linzhen
    Ding, Yuwei
    Shen, Hong
    Yuan, Ying
    CURRENT PROBLEMS IN CANCER, 2021, 45 (03)
  • [50] CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY
    Frances, Meagher Margaret
    Cesare, Saitta
    Clara, Cerrato
    Ithaar, Derweesh
    Andrea, Minervini
    Riccardo, Campi
    Carme, Mir
    Giacomo, Rebez
    Riccardo, Autorino
    Maximilian, Kriegmair
    Estefania, Linares
    Vital, Hevia
    Maria, Musquera
    Eduard, Rousel
    Nicola, Pavan
    Alessandro, Antonelli
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S5 - S5
12345